U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25 NOTIFICATION OF LATE FILING
(Check One):
[X] Form 10-K or Form 10-KSB [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q or
Form 10-QSB [ ] Form N-SAR
For Period Ended: February 29, 2000
[ ] Transition Report on Form 10-K or Form 10-KSB
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q or Form 10-QSB
[ ] Transition Report on Form N-SAR
For the Transition Period Ended: N/A
________________________________________________________________________________
Read Attached Instruction Sheet Before Preparing Form. Please print or type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
________________________________________________________________________________
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: N/A
________________________________________________________________________________
Part I - Registrant Information
Full Name of Registrant: Health Outcomes Management, Inc.
Former Name If Applicable: Data Med Clinical Support Services, Inc.
Address of Principal Executive Office (Street and Number):
2331 University Avenue SE
Minneapolis, MN 55414
Part II - Rules 12b-25(b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)
[X] (a)The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b)The subject annual report, semi-annual report, transition report on
Form 10-K or Form 10-KSB, Form 20-F, 11-K or Form N-SAR, or portion
thereof will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly report
or transition report on Form 10-Q or Form 10-QSB, or portion thereof
will be filed on or before the fifth calendar day following the
prescribed due date; and
[ ] (c)The accountant's statement or other exhibit required by the Rule
12b-25(c) has been attached if applicable.
Part III - Narrative
State below in reasonable detail the reasons why the Form 10-K and Form 10-KSB,
20-F, 11-K, 10-Q and Form 10-QSB, N-SAR or the transition report or portion
thereof could not be filed within the prescribed time period.
The Registrant is unable to file its Annual Report on Form 10-KSB within the
prescribed time period because of the diversion of the Registrant's financial
management resources to efforts surrounding negotiations, finalization of
approvals, and administrative matters related to a proposed partial or complete
acquisition of the Company, or purchase of a portion of the Company's assets.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to this
notification.
Peter Zugschwert (612) 378-3053
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If answer is no
identify reports.
[X] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Health Outcomes Management, Inc.
__________________________________________________________
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date April 4, 2000 By /s/ Peter J. Zugschwert
_____________ ___________________________________
Peter Zugschwert, President and CEO
